Frequency of Interrupting Sitting and Cognitive Function

NCT ID: NCT06700187

Last Updated: 2026-01-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

33 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-03

Study Completion Date

2026-03-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Rationale: Sedentary behavior (SB) has been associated with impaired cognitive function in elderly, and negatively impacts glucose metabolism. Interrupting sitting with physical activity (PA) bouts may exert beneficial effects on cognitive function via an improved glucose metabolism. Nevertheless, the impact of breaking up prolonged sitting with various frequencies of PA bouts remains unexplored in young sedentary adults. Moreover, we hypothesize that the pattern of the breaks modifies the effects. Thus, randomized controlled trials (RCTs) are highly needed to investigate the effects of interrupting sitting with different frequencies of PA on cognitive function and glucose metabolism. We now hypothesize that interrupting sitting with different frequencies of walking breaks differentially affects cognitive function and glucose metabolism.

Objective: The aim is to investigate the effects of breaking up sitting with different frequencies of PA bouts on cognitive function and glucose metabolism in young sedentary adults.

Study design: A randomised, controlled cross-over study will be performed, consisting of four interventions in a counterbalanced order: uninterrupted prolonged sitting, short breaks, moderate breaks, and long breaks.

Intervention: Participants will complete four conditions in a randomized, counterbalanced order: sitting (uninterrupted prolonged sitting without any interruptions), short breaks (walk 1 minute every 10 minutes), moderate breaks (walk 3 minutes every 30 minutes), and long breaks (walk 27 minutes during the intervention). Each condition lasts 4.5 hours.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sedentary Behaviors Breaking Prolonged Sitting With Physical Activity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Interrupting sitting

Participants will engage in low-intensity walking breaks in different frequencies for 4.5 hours

Group Type EXPERIMENTAL

Interrupting sitting with walking breaks

Intervention Type OTHER

Participants will engage in 27 minutes walking in different frequencies, including short breaks (walk 1 minute every 10 minutes), moderate breaks (walk 3 minutes every 30 minutes), and long breaks (walk 27 minutes in one time during the intervention).

Control

Paticipants will remain seated for 4.5 hours

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Interrupting sitting with walking breaks

Participants will engage in 27 minutes walking in different frequencies, including short breaks (walk 1 minute every 10 minutes), moderate breaks (walk 3 minutes every 30 minutes), and long breaks (walk 27 minutes in one time during the intervention).

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women aged 18-35 years;
* BMI between 18.5-24.9 kg/m2;
* SB, i.e. sitting for an average of at least 9 hours per day;
* Physically inactive, i.e. engaging in exercise for less than 2 to 3 times per week;
* Stable body weight (weight gain or loss \< 3 kg in the past three months);
* Willingness to engage in four 6-hour laboratory visits;
* No difficult cannulation.

Exclusion Criteria

* Not sedentary, i.e. sitting for less than an average of 9 hours per day;
* Physically active, i.e. engaging in exercise for more than 3 times a week;
* Abuse of drugs;
* Use medication to treat BP, lipid, or glucose metabolism;
* Pregnant females.
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Maastricht University Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nutrition and movement science

Maastricht, , Netherlands

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Renyan Ma

Role: CONTACT

+31 883887804

Hans Savelberg, Phd

Role: CONTACT

+31 433881392

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Role: primary

+31 (0)883887804

References

Explore related publications, articles, or registry entries linked to this study.

Wheeler MJ, Green DJ, Cerin E, Ellis KA, Heinonen I, Lewis J, Naylor LH, Cohen N, Larsen R, Dempsey PC, Kingwell BA, Owen N, Dunstan DW. Combined effects of continuous exercise and intermittent active interruptions to prolonged sitting on postprandial glucose, insulin, and triglycerides in adults with obesity: a randomized crossover trial. Int J Behav Nutr Phys Act. 2020 Dec 14;17(1):152. doi: 10.1186/s12966-020-01057-9.

Reference Type BACKGROUND
PMID: 33308235 (View on PubMed)

Homer AR, Taylor FC, Dempsey PC, Wheeler MJ, Sethi P, Townsend MK, Grace MS, Green DJ, Cohen ND, Larsen RN, Kingwell BA, Owen N, Dunstan DW. Frequency of Interruptions to Sitting Time: Benefits for Postprandial Metabolism in Type 2 Diabetes. Diabetes Care. 2021 Jun;44(6):1254-1263. doi: 10.2337/dc20-1410. Epub 2021 Apr 26.

Reference Type BACKGROUND
PMID: 33905343 (View on PubMed)

Duran AT, Friel CP, Serafini MA, Ensari I, Cheung YK, Diaz KM. Breaking Up Prolonged Sitting to Improve Cardiometabolic Risk: Dose-Response Analysis of a Randomized Crossover Trial. Med Sci Sports Exerc. 2023 May 1;55(5):847-855. doi: 10.1249/MSS.0000000000003109. Epub 2023 Jan 12.

Reference Type BACKGROUND
PMID: 36728338 (View on PubMed)

Wheeler MJ, Green DJ, Ellis KA, Cerin E, Heinonen I, Naylor LH, Larsen R, Wennberg P, Boraxbekk CJ, Lewis J, Eikelis N, Lautenschlager NT, Kingwell BA, Lambert G, Owen N, Dunstan DW. Distinct effects of acute exercise and breaks in sitting on working memory and executive function in older adults: a three-arm, randomised cross-over trial to evaluate the effects of exercise with and without breaks in sitting on cognition. Br J Sports Med. 2020 Jul;54(13):776-781. doi: 10.1136/bjsports-2018-100168. Epub 2019 Apr 29.

Reference Type BACKGROUND
PMID: 31036563 (View on PubMed)

Wu Y, Van Gerven PWM, de Groot RHM, Eijnde BO, Winkens B, Savelberg HHCM. Effects of breaking up sitting with light-intensity physical activity on cognition and mood in university students. Scand J Med Sci Sports. 2023 Mar;33(3):257-266. doi: 10.1111/sms.14277. Epub 2022 Dec 1.

Reference Type BACKGROUND
PMID: 36434768 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CCMO, WMO

Identifier Type: REGISTRY

Identifier Source: secondary_id

NL86254.068.24

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Metacognition in Neurological Injury
NCT03752697 ACTIVE_NOT_RECRUITING
Brain Balance Study
NCT05714150 RECRUITING NA